Intra-Cellular Therapies Inc. buy Vassago1
Start price
16.12.21
/
50%
€32.60
Target price
16.12.22
-
Performance (%)
38.19%
End price
25.12.21
€45.05
Summary
This prediction ended on 25.12.21 with a price of €45.05. With a performance of 38.19% the BUY prediction by Vassago1 was a big success. Vassago1 has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Intra-Cellular Therapies Inc. | - | - | - | - |
| iShares Core DAX® | 1.301% | -1.386% | 12.259% | 59.752% |
| iShares Nasdaq 100 | 0.612% | -4.172% | 1.687% | 86.147% |
| iShares Nikkei 225® | 8.772% | 9.777% | 30.041% | 63.047% |
| iShares S&P 500 | 0.254% | -2.301% | 0.794% | 57.981% |
According to Vassago1 what are the pros and cons of Intra-Cellular Therapies Inc. for the foreseeable future?
Pros
Could be worthwhile Investment >10% per year
Cons
Comments by Vassago1 for this prediction
In the thread Intra-Cellular Therapies Inc. diskutieren
Buy Intra-Cellular Therapies Inc.